Business

Mass. movers

Cerulean drug shows antitumor potential

The Cerulean drug is used to treat ovarian cancer.

Associated Press/File 2014

The Cerulean drug is used to treat ovarian cancer.

Advertisement

Cerulean Pharma Inc., of Cambridge, announced that its CRLX101, a proprietary investigational drug, exhibits powerful antitumor properties, according to preclinical data. The drug was potent alone as well as in combination with Avastin, a Genentech Inc. cancer drug. “The combination of CRLX101 and Avastin is synergistic, with the potential to enhance survival of patients with ovarian cancer,” said Robert S. Kerbel, a researcher on the manuscript of data released Tuesday.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com